Saudi consensus guidance for the diagnosis and management of inflammatory bowel disease in children and adolescents

Omar I. Saadah; Turki AlAmeel; Ahmed Al Sarkhy; Mohammed Hasosah; Abdulrahman Al-Hussaini; Majid A. Almadi; Badr Al-Bawardy; Talal A. Altuwaijri; Mohammed AlEdreesi; Shakir A. Bakkari; Othman R. Alharbi; Nahla A. Azzam; Abdulelah Almutairdi; Khalidah A. Alenzi; Bedor A. Al-Omari; Hajer Y. Almudaiheem; Ahmed H. Al-Jedai; Mahmoud H. Mosli

doi:10.4103/sjg.sjg_171_24

الاقتباسات

392

المشاهدات

الملخص

Abstract
The management of inflammatory bowel disease (IBD) in children and adolescents is challenging. Clear evidence-based guidelines are required for this population. This article provides recommendations for managing IBD in Saudi children and adolescents aged 6–19 years, developed by the Saudi Ministry of Health in collaboration with the Saudi Society of Clinical Pharmacy and the Saudi Gastroenterology Association. All 57 guideline statements are based on the most up-to-date information for the diagnosis and management of pediatric IBD.

الاستشهاد بهذا المقال (APA)

Omar, I. S., Turki, A., Ahmed, A. S., Mohammed, H., Abdulrahman, A., Majid, A. A., Badr, A., Talal, A. A., Mohammed, A., Shakir, A. B., Othman, R. A., Nahla, A. A., Abdulelah, A., Khalidah, A. A., Bedor, A. A., Hajer, Y. A., Ahmed, H. A., Mahmoud, H. M. (2024). Saudi consensus guidance for the diagnosis and management of inflammatory bowel disease in children and adolescents. Saudi Journal of Gastroenterology. https://doi.org/10.4103/sjg.sjg_171_24

Saleh A. Alqahtani; Faisal Abaalkhail; Saad Alghamdi; Khalid Bzeizi; Waleed K. A · 2024

استشهاد

397

CEBPB dampens the cuproptosis sensitivity of colorectal cancer cells by facilitating the PI3K/AKT/mT…

Tianchen Huang; Yong Zhang; Yachao Wu; Xiaodong Han; Lei Li; Zhipeng Guo; Kan Li · 2024

استشهاد

398

SASLT guidelines: Update in treatment of hepatitis C virus infection, 2024

Abdullah S. Alghamdi; Hamdan Alghamdi; Haleema A. Alserehi; Mohammed A. Babatin; · 2024

استشهاد

395

The effectiveness of vedolizumab in advanced therapy-experienced ulcerative colitis patients: Real w…